UICC TNM 8 th Edition Errata

Similar documents
UICC TNM 8 th Edition Errata

UICC 8 th Edition Errata 25 th of May 2018

UICC 8th Edition Errata 28 th of January 2019

Prognostic factors of genitourinary tumors: Do we have to care?

TNM Classification of Malignant Tumours 8 th edition

The pathology of bladder cancer

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Staging and Treatment Update for Gynecologic Malignancies

AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-

GUIDELINES ON RENAL CELL CANCER

Carcinoma of the Urinary Bladder Histopathology

AJCC 7th Edition Handbook Errata as of 9/21/10

A215- Urinary bladder cancer tissues

The 8th Edition Lung Cancer Stage Classification

Gastric Cancer Histopathology Reporting Proforma

25 TH ICRO DEHRADUN STAGING OF GENITOURINARY MALIGNANCIES

TOPICS FOR DISCUSSION

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

Vulvar Carcinoma. Definition: Cases should be classified as carsinoma of the vulva when the primary site growth is in the vulva Malignant melanoma sho

Testicular Malignancies /8/15

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Carcinoma of the Renal Pelvis and Ureter Histopathology

Urinary Bladder, Ureter, and Renal Pelvis

RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

SEER Summary Stage Still Here!

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours

B REAST STAGING FORM. PATHOLOGIC Extent of disease through completion of definitive surgery. CLINICAL Extent of disease before any treatment

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

GUIDELINES ON RENAL CELL CARCINOMA

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Major Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

6 th Reprint Manual Pages AJCC 7 th Edition

8th Edition of the TNM Classification for Lung Cancer. Proposed by the IASLC

2009 USCAP Gyn Pathology Evening Session Case #3. Richard J. Zaino, MD Hershey Medical Center Penn State University Hershey, PA

Guidelines on Renal Cell

H&E, IHC anti- Cytokeratin

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Oral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi

AJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx

Definition of Synoptic Reporting

6 th Reprint Handbook Pages AJCC 7 th Edition

GUIDELINES ON PENILE CANCER

Interactive Staging Bee

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

Genitourinary Neoplasms Updated for 2012 Requirements and CSv02.04

The 8 th Edition of TNM for Lung Cancer: The IASLC Proposals.

Renal Parenchymal Neoplasms

Urinary Bladder, Ureter, and Renal Pelvis

VULVAR CARCINOMA. Page 1 of 5

STAGE CATEGORY DEFINITIONS

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

A916: rectum: adenocarcinoma

Cancer: recent advances and implications for underwriting

Cervical Cancer: 2018 FIGO Staging

Comprehensive Cancer Cover

Type I. Type II. Excess estrogen Lynch Endometrioid adenocarcinoma PTEN. High grade More aggressive Serous, Clear Cell p53

AJCC Cancer Staging Form Supplement

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

Table of Contents Comparison Chart

EAU GUIDELINES ON PENILE CANCER

Penile cancer teams in UK. Common variants. Penile cancer teams. Basaloid squamous carcinoma. The Pathology of Penile Tumours

The functional anatomy of the urinary system. Human Anatomy Department Dr. Anastasia Bendelic

Neoplasms of the Prostate and Bladder

L ARYNX S TAGING F ORM

The new TNM staging for renal cell carcinoma: what and why the urologists want to know.

Carcinoma of the Fallopian Tube

47. Melanoma of the Skin

George Cernile Artificial Intelligence in Medicine Toronto, ON. Carol L. Kosary National Cancer Institute Rockville, MD

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

Guideline for the Management of Vulval Cancer

You Want ME to Stage that Case???

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Uterine Malignancies. Collecting Cancer Data: Uterine Malignancies 10/7/2010. NAACCR Webinar Series 1. Questions. Fabulous Prizes!!!

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

LYMPHATIC DRAINAGE IN THE HEAD & NECK

S1.04 Principal clinician. G1.01 Comments. G2.01 *Specimen dimensions (prostate) S2.02 *Seminal vesicles

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

NAACCR Webinar Series 1

Comprehensive cancer cover

Transcription:

UICC TNM 8 th Edition Errata ions are in italics Head and Neck Tumours Pages 20, p27, p34, p38, p41, and p49 ly pn2a Metastasis in a single ipsilateral lymph node, less than 3cm in greatest dimension with extranodal extension or more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension pn2a Metastasis in a single ipsilateral lymph node, 3cm or less in greatest dimension with extranodal extension or more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension Page 24 ly T3 or T3 or Hypopharynx Tumour more than 4 cm in greatest dimension, or with fixation of hemilarynx extension to oesophagus Tumour more than 4 cm in greatest dimension, or with fixation of hemilarynx extension to oesophageal mucosa Page 28 Oropharynx p16 positive Clinical Stage III T4 Any M0 Stage III T4 AnyN M0 1

Pathological Stage II T1,T2 N2 M0 T3 N0,N1 M0 Stage II T1,T2 N2 M0 T3,T4 N0,N1 M0 Page 59 Oesophagus Squamous cell Carcinoma Pathological Stage Stage IVA T4a N2 M0 T4b AnyN M0 Any T N3 M0 Stage IV AnyT AnyN M1 Stage IVA T4a N2 M0 T4b AnyN M0 Any T N3 M0 Stage IVB AnyT AnyN M1 Page 61 Oesophagus Adenocarcinoma Pathological Prognostic Group T N M Grade Group IB T1a N0 M0 2, T1b N0 M0 1, 2 Group IIIA T1 N2 M0 Any T2 N1 M0 Any T3, N0 M0 Any Group IB T1a N0 M0 2 2

T1b N0 M0 1, 2, X Group IIIA T1 N2 M0 Any T2 N1 M0 Any T3 N0 M0 Any Delete Page 72 Stage IVA Stage IVA Appendix Any T Any N0 M1a Any T Any N M1a Any T Any N M1b G1 Page 92 Ampulla of Vater N Regional Lymph Nodes NX N0 N1 N2 Regional lymph nodes cannot be assessed No regional lymph node metastasis Metastasis in 1 or 2 regional lymph nodes Metastasis in 3 or more regional lymph nodes N Regional Lymph Nodes NX N0 N1 N2 Regional lymph nodes cannot be assessed No regional lymph node metastasis Metastasis in 1 to 3 regional lymph nodes Metastasis in 4 or more regional lymph nodes Page 94 Pancreas T1 T1 Tumour 2 cm or less in greatest dimension T1a Tumour 0.5 cm or less in greatest dimension T1b Tumour greater than 0.5 cm and less than 1 cm in greatest dimension T1c Tumor greater than 1 cm but no more than 2 cm in greatest dimension Tumour 2 cm or less in greatest dimension T1a Tumour 0.5 cm or less in greatest dimension T1b Tumour greater than 0.5 cm and no more than 1 cm in greatest dimension T1c Tumor greater than 1 cm but no more than 2 cm in greatest dimension Page 113 Pleural Mesothelioma 3

T1 Tumour involves ipsilateral parietal or visceral pleura only, with or without involvement of visceral, mediastinal or diaphragmatic pleura. T1 Tumour involves ipsilateral parietal or visceral pleura only, with or without involvement of visceral, mediastinal or diaphragmatic pleura. Page 143 pt1 Melanoma Tumour 1 mm or less in thickness pt1a 0.8mm or less in thickness without ulceration pt1b 0.8mm or less in thickness with ulceration or more than 0.8mm but no more than 1mm in thickness, with or without ulceration pt1 Tumour 1 mm or less in thickness pt1a less than 0.8mm in thickness without ulceration pt1b less than 0.8mm in thickness with ulceration or 0.8mm or more but no more than 1mm in thickness, with or without ulceration Page 173/4 Uterine sarcoma Stage III T1, T2, T3 N1, N2 M0 Stage IIIC1 T1, T2, T3 N1 M0 Stage IIIC2 T1, T2, T3 N2 M0 Stage IIIC T1, T2, T3 N1, N2 M0 Stage IIIC1 T1, T2, T3 N1 M0 Stage IIIC2 T1, T2, T3 N2 M0 Page 179 Ovary Regional Lymph Nodes The regional lymph nodes are the hypogastric (obturator), common iliac, external iliac, lateral sacral, paraaortic, retroperitoneal, and inguinal nodes. Regional Lymph Nodes The regional lymph nodes are the hypogastric (obturator), common iliac, external iliac, lateral sacral, paraaortic, and retroperitoneal nodes* * Note *including intra-abdominal node such as greater omental nodes. 4

Page 182 Ovary M Distant Metastasis M0 M1 No distant metastasis Distant metastasis M Distant Metastasis M0 No distant metastasis M1 Distant metastasis M1a Pleural effusion with positive cytology M1b Parenchymal metastasis and metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity) Stage Stage I T1 N0 M0 Stage IA T1a N0 M0 Stage IB T1b N0 M0 Stage IC T1c N0 M0 Stage II T2 N0 M0 Stage IIA T2a N0 M0 Stage IIB T2b N0 M0 Stage IIC T2c N0 M0 Stage Stage I T1 N0 M0 Stage IA T1a N0 M0 Stage IB T1b N0 M0 Stage IC T1c N0 M0 Stage II T2 N0 M0 Stage IIA T2a N0 M0 Stage IIB T2b N0 M0 Stage IIC T2c N0 M0 Page 186 - Gestational Throphoblastic Neoplasms : Pretreatment <10 3 10 3 < 10 4 10 4 < 10 5 >10 5 serum hcg (IU/ml) Pretreatment <10 3 10 3 < 10 4 10 4 < 10 5 10 5 serum hcg(iu/ml) 5

Page 188 Penis T Primary Tumour Tis Carcinoma in situ Ta Noninvasive verrucous carcinoma 1 T1 Tumour invades subepithelial connective tissue T1a Tumour invades subepithelial connective tissue without lymphovascular invasion and is not poorly differentiated T1b Tumour invades subepithelial connective tissue with lymphovascular invasion or is poorly differentiated Note: 1 Verrucous carcinoma not associated with destructive invasion. Tis Carcinoma in situ (Penile intraepithelial neoplasia PeIN) Ta Noninvasive localized squamous cell carcinoma 1 T1 Tumour invades subepithelial connective tissue 2 T1a Tumour invades subepithelial connective tissue without lymphovascular invasion or perineural invasion and is not poorly differentiated T1b Tumour invades subepithelial connective tissue with lymphovascular invasion or perineural invasion or is poorly differentiated Note: 1 Including verrucous carcinoma. 2 Glans: Tumor invades lamina propria Foreskin: Tumor invades dermis, lamina propria or dartos fascia Shaft: Tumor invades connective tissue between epidermis and corpora and regardless of location Page 191, 193 Prostate T3 Tumour extends through the prostatic capsule 2 T3a Extracapsular extension (unilateral or bilateral) including microscopic bladder neck involvement T3 Tumour extends through the prostatic capsule 2 T3a Extraprostatic extension (unilateral or bilateral) including microscopic bladder neck involvement Prognostic Factor Grid Gleason Sum Score 6

Page 198 Testis Stage IIA Any pt/tx N1 M0 S0 Any pt/tx N1 M0 S1 Stage IIB Any pt/tx N2 M0 S0 Any pt/tx N2 M0 S1 Stage II Any pt/tx N3 M0 S0 Any pt/tx N3 M0 S1 Stage IIA Any pt/tx N1 M0 S0 Any pt/tx N1 M0 S1 Stage IIB Any pt/tx N2 M0 S0 Any pt/tx N2 M0 S1 Stage IIC Any pt/tx N3 M0 S0 Any pt/tx N3 M0 S1 Page 199 Kidney T Primary Tumour T3 Tumour grossly extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota fascia T3a Tumour extends into the renal vein or its segmental (muscle containing) branches, or tumour invades perirenal and/or renal sinus fat (peripelvic) fat but not beyond Gerota fascia T3b Tumour grossly extends into vena cava below diaphragm T3c Tumour grossly extends into vena cava above the diaphragm or invades the wall of the vena cava T3 Tumour grossly extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota fascia T3a Tumour extends into the renal vein or its segmental (muscle containing) branches, or tumour invades the pelvicalyceal system or tumour invades perirenal and/or renal sinus fat (peripelvic) fat but not beyond Gerota fascia T3b Tumour grossly extends into vena cava below diaphragm T3c Tumour grossly extends into vena cava above the diaphragm or invades the wall of the vena cava Page 204, 205 Urinary Bladder T2 Tumour invades muscle T2a Tumour invades superficial muscle (inner half) T2b Tumour invades deep muscle (outer half) 7

Stage IVA T4b N0 M0 T2 Tumour invades muscularis propria T2a Tumour invades superficial muscularis propria (inner half) T2b Tumour invades deep muscularis propria (outer half) Stage IVA Any T Any N M1a Page 208 Urethra Urothelial (Transitional cell) carcinoma of the prostate Tis pu Tis pd Carcinoma in situ, involvement of prostatic urethra Carcinoma in situ, involvement of prostatic ducts Urothelial (Transitional cell) carcinoma of the prostate Tis pu Carcinoma in situ, involving the prostatic urethra, periurethral or prostatic ducts without stromal invasion Page 224 Malignant Melanoma of the Uvea Stage* Note *The stage groups are for malignant melanoma of the choroid and ciliary body but not the of the Iris Page 232 Lacrimal Gland T2 Tumour more than 2 cm but not more than 4 cm in greatest dimension, limited to the lacrimal gland T2a No periosteal or bone involvement T2b Periosteal involvement without bone involvement T2c Bone involvement T2 Tumour more than 2 cm but not more than 4 cm in greatest dimension, limited to the lacrimal gland T2a No periosteal or bone involvement T2b Periosteal involvement without bone involvement T2c Bone involvement 8